A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage

Critical Care and Resuscitation

Volumn 15, Issue 2, 2013, Pages 119-125

  Bradford, Celia M ^a   Finfer, Simon ^a,b   O'Connor, Anne ^a   Yarad, Elizabeth ^a   Firth, Rochelle ^a   McCallister, Richard ^c   Harrington, Tim ^a   Steinfort, Brendan ^a   Faulder, Ken ^a   Assaad, Nazih ^a,d   Morgan, Michael ^a,d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL HOBART HOSPITAL   (Australia)

^d MACQUARIE UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM; MAGNESIUM SULFATE;

AGED; ARTICLE; BLOOD; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; INTRACRANIAL ANEURYSM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROGNOSIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; CEREBRAL ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL ANEURYSM; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; PROGNOSIS; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 84883461789     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995; 23: 1007-1017.
2. Weir B, MacDonald L. Cerebral vasospasm. Clin Neurosurg 1993; 40: 40-55.
3. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001; 48: 249-261; discussion 261-2.
4. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 510-514. doi: 10.3171/jns.2002.96.3.0510.
5. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36:1011-1015. doi: 10.1161/01.str.0000160801.96998.57.
6. Stippler M, Crago E, Levy EI, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105: 723-729. doi: 10.3171/jns.2006.105.5.723.
7. Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med 2010; 38: 1284-1290. doi: 10.1097/CCM.0b013e3181d9da1e.
8. Wong GK, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010; 41: 921-926. doi:10.1161/strokeaha.109.571125.
9. Muroi C, Terzic A, Fortunati M, et al. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008; 69: 33-9.
10. Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomized placebo-controlled trial. Lancet 2012; 380: 44-49. doi: S0140-6736(12)60724-7.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
12. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988; 51: 1457.
13. Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011; 42: 919-923. doi: 10.1161/strokeaha.110.597005
14. Diringer MN, Bleck TP, Claude Hemphill J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011; 15: 211-240.
15. Wong GK, Boet R, Poon WS, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011; 15: R52.
16. Schmid-Elsaesser R, Kunz M, Zausinger S, et al. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006; 58: 1054-1065.
17. El Beltagy M, Muroi C, Imhof HG, Yonekawa Y. Peripheral large or giant fusiform middle cerebral artery aneurysms: report of our experience and review of literature. Acta Neurochir Suppl 2008; 103: 37-44.